Probiotic Cocktail to Slow Early Parkinson's Disease
Part of Brain & nervous system clinical trials.
This study tests whether a special blend of probiotics (good bacteria), an amino acid called tryptophan, and branched-chain amino acids can help slow the progression of early-stage Parkinson's disease. The idea is that these supplements may work through your gut bacteria to help protect your brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 85 years old
- You have been diagnosed with early-stage Parkinson's disease (mild to moderate symptoms)
- Your brain MRI shows changes in a specific area called the basal ganglia, with no history of stroke
- Your Parkinson's symptoms improve with standard Parkinson's medications like Levodopa
- You do not have any major acute illnesses right now
- You can attend study visits and take the supplement for 12 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking probiotics can improve REM sleep behavior disorder (RBD) in people with Parkinson's disease. You will receive either a probiotic supplement or a placebo, and researchers will use brain scans to see how it affects your symptoms.
This research examines how the gut and brain are connected in Parkinson's disease and aims to better understand the disease. You'd participate in visits and tests over three years, including some involving your digestive system.
This trial tests whether a supplement called L-theanine and a Mediterranean diet can improve sleep, digestion, and inflammation in early-stage Parkinson's disease. It may help if you are in stage 1 and live with a healthy partner.
This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.
This study looks at the germs in your gut and certain chemicals they make, which may relate to Parkinson's disease. It compares people with Parkinson's to healthy people of similar age and body size to see if there are differences.
This trial tests whether transplanting healthy gut bacteria from a donor can help reduce motor complications (like involuntary movements or on-off medication cycles) in people with Parkinson's disease who have had the condition for at least 5 years.
Hear when a new Gut Microbiota trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.